Patent directory · USPTO A61K / A61P
Patents matching “pd-”
81 pharma patents match "pd-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 81 pharmaceutical patents matching "pd-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11421034
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
granted -
US 11357842
PD-L1 targeting DNA vaccine for cancer immunotherapy
granted -
US 11324822
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
granted -
US 11292842
Anti-PD-1 antibodies for treatment of lung cancer
granted -
US 11254752
Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies
granted -
US 11254746
Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof
granted -
US 11141434
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof
granted -
US 11117970
Human antibodies to PD-L1
granted -
US 10982215
Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
granted -
WO 2021064188
COMBINAISON COMPRENANT UN INHIBITEUR DE HDAC, UN INHIBITEUR DE CTLA-4 ET UN INHIBITEUR DE PD-1 OU UN INHIBITEUR DE PD-L1 POUR LE TRAITEMENT DU CANCER
granted -
US 10889813
Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
granted -
US 10858432
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted -
US 10836827
Antibodies specific to glycosylated PD-L1 and methods of use thereof
granted -
US 10822414
Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies
granted -
US 10786552
Il-2Rβ-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 antibody
granted -
US 10744116
Detection and treatment of anti-PD-1 therapy resistant metastatic melanomas
granted -
US 10745704
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
granted -
US 10737113
Human antibodies to PD-1
granted -
US 10736976
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted -
US 10683347
Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies
granted -
US 10618967
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
granted -
EP 3630112
KOMBINATION AUS REGORAFENIB UND PD-1/PD-L1(2)-INHIBITOREN ZUR BEHANDLUNG VON KREBS
granted -
US 10457725
Methods of treating skin cancer by administering a PD-1 inhibitor
granted -
CA 3097087
COMBINAISON COMPRENANT UN INHIBITEUR DE HDAC, UN INHIBITEUR DE LAG-3 ET UN INHIBITEUR DE PD-1 OU UN INHIBITEUR DE PD-L1 POUR LE TRAITEMENT DU CANCER
granted